APA (7th ed.) Citation

A, B., A, S., G, K., OK, S., DM, G., FL, R., & V, S. (2026). Evaluating AL-ISS within a BNP-based model for AL amyloidosis in the daratumumab era. Blood advances, 10(13), 4612. https://doi.org/10.1182/bloodadvances.2026020177

Chicago Style (17th ed.) Citation

A, Berumen, Staron A, Kalaitzidis G, Siddiqi OK, Gopal DM, Ruberg FL, and Sanchorawala V. "Evaluating AL-ISS Within a BNP-based Model for AL Amyloidosis in the Daratumumab Era." Blood Advances 10, no. 13 (2026): 4612. https://doi.org/10.1182/bloodadvances.2026020177.

MLA (9th ed.) Citation

A, Berumen, et al. "Evaluating AL-ISS Within a BNP-based Model for AL Amyloidosis in the Daratumumab Era." Blood Advances, vol. 10, no. 13, 2026, p. 4612, https://doi.org/10.1182/bloodadvances.2026020177.